Zero-Click Contouring: Automatic OAR and LNL Contouring for Dosimetrists and PhysiciansCLEVELAND, OH / ACCESSWIRE / December 5, 2023 / MIM…
Zero-Click Contouring: Automatic OAR and LNL Contouring for Dosimetrists and PhysiciansCLEVELAND, OH / ACCESSWIRE / December 5, 2023 / MIM…
FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today…
BMF-219 is a novel investigational covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes…
Upcoming PDUFA goal date of January 3, 2024 U.S. patent protection for cosibelimab through at least May 2038 WALTHAM, Mass.,…
ANGLE LAUNCHES PORTRAIT+ CTC KIT AT SAN ANTONIO BREAST CANCER SYMPOSIUMANGLE's Portrait+ CTC staining kit combines the power of Parsortix®…
LeanTaaS experiences 170% revenue growth year-to-date over the last three years, including over 50% growth year-over-year for iQueue for Operating…
VIENNA, Va.--(BUSINESS WIRE)--$CVM #Multikine--CEL-SCI Corporation (NYSE American: CVM) today announced that the British National Institute for Health and Care Excellence…
VIENNA, Va.--(BUSINESS WIRE)--$CVM #Multikine--CEL-SCI Corporation (NYSE American: CVM) today announced that the British National Institute for Health and Care Excellence…
Canalevia®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from…